We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

196 hedge funds and large institutions have $2.31B invested in Stoke Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 27

52% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 52

9% more capital invested

Capital invested by funds: $2.13B → $2.31B (+$189M)

7% more funds holding

Funds holding: 183 → 196 (+13)

2.94% more ownership

Funds ownership: 117.28% → 120.21% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

57% less call options, than puts

Call options by funds: $3.7M | Put options by funds: $8.68M

Holders
196
Holders Change
+13
Holders Change %
+7.1%
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
43
Increased
79
Reduced
52
Closed
27
Calls
$3.7M
Puts
$8.68M
Net Calls
-$4.98M
Net Calls Change
-$22.7M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$77.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$51.2M
3
TCA
Troluce Capital Advisors
Puerto Rico
+$21.4M
4
Millennium Management
Millennium Management
New York
+$15.5M
5
Bank of America
Bank of America
North Carolina
+$11M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.8M
2
LCM
Lynx1 Capital Management
Puerto Rico
-$21M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$10.5M
4
Goldman Sachs
Goldman Sachs
New York
-$10.2M
5
SL
Siren LLC
Connecticut
-$8.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
76
Boothbay Fund Management
New York
$1.54M +$1.55M +47,307 New
AA
77
ALPS Advisors
Colorado
$1.51M -$656K -20,004 -30%
AQR Capital Management
78
AQR Capital Management
Connecticut
$1.51M +$557K +16,992 +58%
OAC
79
OMERS Administration Corp
Ontario, Canada
$1.35M +$1.36M +41,500 New
PIM
80
Platinum Investment Management
Australia
$1.33M – – –
AllianceBernstein
81
AllianceBernstein
Tennessee
$1.33M +$39.4K +1,200 +3%
Deutsche Bank
82
Deutsche Bank
Germany
$1.32M +$236K +7,190 +22%
MWM
83
Moran Wealth Management
Florida
$1.32M +$1.33M +40,552 New
New York State Common Retirement Fund
84
New York State Common Retirement Fund
New York
$1.27M +$791K +24,123 +160%
LPL Financial
85
LPL Financial
California
$1.17M +$940K +28,667 +388%
CM
86
Caption Management
Oklahoma
$1.15M +$1.15M +35,174 New
SG Americas Securities
87
SG Americas Securities
New York
$1.11M +$268K +8,160 +32%
Victory Capital Management
88
Victory Capital Management
Texas
$1.1M -$238K -7,250 -18%
Mirae Asset Global ETFs Holdings
89
Mirae Asset Global ETFs Holdings
Hong Kong
$1.1M +$44.5K +1,358 +4%
Schroder Investment Management Group
90
Schroder Investment Management Group
United Kingdom
$1.08M +$1.12M +34,102 New
Legal & General Group
91
Legal & General Group
United Kingdom
$1.04M -$142K -4,318 -12%
Blackstone Inc
92
Blackstone Inc
New York
$996K +$1M +30,579 New
Los Angeles Capital Management
93
Los Angeles Capital Management
California
$992K +$698K +21,273 +231%
PA
94
Profund Advisors
Maryland
$879K -$210K -6,403 -19%
Nomura Holdings
95
Nomura Holdings
Japan
$876K -$573K -17,461 -39%
VGA
96
Vanguard Global Advisers
Pennsylvania
$867K +$874K +26,639 New
Canada Pension Plan Investment Board
97
Canada Pension Plan Investment Board
Ontario, Canada
$853K -$295K -9,000 -26%
MIM
98
MetLife Investment Management
New Jersey
$850K +$25.8K +786 +3%
VAM
99
Vanguard Asset Management
$818K +$824K +25,114 New
CAM
100
Cresset Asset Management
Illinois
$798K -$60K -1,831 -7%
2 3
4
5 6

STOK Hedge Fund Activity: Q1 2026 in Review

196 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2026, worth a combined $2.31B — up 8.9% from $2.13B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new STOK positions and 27 closed out — a net gain of 16 holders — while 79 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $38.8M sold.

  • 196 institutional investors held Stoke Therapeutics (STOK) as of Q1 2026, up from 183 in Q4 2025.
  • Funds reported $2.31B of Stoke Therapeutics stock for Q1 2026, up 8.9% quarter-over-quarter.
  • 43 funds opened new Stoke Therapeutics positions in Q1 2026 and 27 closed out, a net change of +16 holders.
  • The largest Stoke Therapeutics buyer in Q1 2026 was Wellington Management Group, an estimated $77.4M added.
  • The largest Stoke Therapeutics seller in Q1 2026 was Point72 Asset Management, an estimated $38.8M sold.

Based on aggregated 13F filings for Q1 2026.